glp-1 obesity drug news today drugs Market Overview: GLP-1 Agonists and the Obesity Market The popularity of GLP-1 drugs
Description
10.1016/S0140-6736(08)61246-5 44 GaultV
Articles of all types were included in this review if the inclusion/exclusion criteria were met
For someone with well-controlled blood pressure, a modest increase may be clinically insignificant
2022;14:e21536
[DOI] [PMC free article] [PubMed] [Google Scholar] 125.Murphy W.A., Coy D.H., Lance V.A
Insights from Roots Analysis highlight this shift and its impact on global healthcare
